Covis Pharma
@covispharma.com
Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses. Our purpose is to turn untapped potential into global medical therapies that improve our patients' lives. Apollo Global Management, with $455 billion AUM, is the private equity sponsor of Covis Pharma.
Covis Pharma's Company Logos
Covis Pharma's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#33A7B5
Pelorous
51, 167, 181
186, 56, 45
72, 8, 0, 29
#9896F0
Portage
152, 150, 240
241, 75, 76
37, 37, 0, 6
#93C90E
Bahia
147, 201, 14
77, 87, 42
27, 0, 93, 21
About Covis Pharma
Covis Pharma is a global specialty pharmaceutical company founded in 2011. Dedicated to improving the lives of patients with life-threatening conditions and chronic illnesses, we offer a diverse portfolio of therapeutic solutions available in over 50 countries. Our strong senior management team ensures operational excellence and strategic partnerships with leading pharmaceutical companies.
Covis Pharma is committed to providing affordable medications while maintaining therapeutic equivalence. In 2018, we acquired global rights to prominent brands like Alvesco®, Omnaris®, and Zetonna®, further expanding our product offerings. Acquired by Apollo Global Management in 2020, Covis Pharma continues to grow, most recently strengthening our respiratory portfolio through acquisitions from AstraZeneca in 2022.
Contact us for medical information or explore our website to learn more about our products and services
Company type
Privately Held
Year founded
2011
Company size
201-500 employees
Related Brands
Tags
Specialty pharmaceutical company
Therapeutically equivalent medications
Authorized generics
Patient assistance programs
